
EBOS shares were selling off before the chemist warehouse announcement, breaking past its past support level as justified given the earnings hole. We trim -11% of previous support level as a technical entry level to reflect the loss in earnings going forward. We see the stock would most likely consolidate now that it is a week after the news flow and remain range bound at a HOLD level for investors.